Effect of a Mobile App on Prehospital Medication Errors During Simulated Pediatric Resuscitation: A Randomized

Johan N Siebert1,2, Laurie Bloudeau3, Christophe Combescure4

  • 1Department of Pediatric Emergency Medicine, Geneva Children's Hospital, Geneva University Hospitals, Geneva, Switzerland.

JAMA Network Open
|August 30, 2021
PubMed

Insights

A mobile app significantly reduced medication errors in pediatric emergencies, decreasing errors by 66.5% and speeding up drug delivery. This innovation shows promise for improving prehospital emergency care safety.

Area of Science:

  • Emergency Medicine
  • Clinical Pharmacology
  • Health Informatics

Background:

  • Medication errors are a significant cause of preventable harm, particularly in pediatric emergency care.
  • There is a lack of innovative interventions to prevent medication errors in prehospital settings.
  • Children are especially vulnerable to medication errors.

Purpose of the Study:

  • To evaluate the effectiveness of an evidence-based mobile application in minimizing medication errors during simulated pediatric out-of-hospital cardiac arrest scenarios.
  • To compare the app's performance against conventional drug preparation methods.

Main Methods:

  • A nationwide, open-label, multicenter randomized clinical trial involving 150 advanced paramedics across 14 Swiss emergency medical services centers.
  • Participants prepared 4 intravenous emergency drugs in simulated pediatric cardiac arrest scenarios.
  • Randomization to either a mobile app for drug preparation assistance or conventional methods.

Main Results:

  • The mobile app group had a significantly lower rate of medication errors (5.7%) compared to the conventional method group (62.8%).
  • The app reduced medication errors by 66.5% and decreased drug preparation and delivery times.
  • Medication error rates varied across drugs, with the app consistently showing lower risks.

Conclusions:

  • Mobile applications can significantly decrease medication errors and improve drug delivery times in prehospital emergency settings.
  • Dedicated mobile apps hold potential for enhancing medication safety and transforming practices in pediatric emergency medicine.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
43
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
55
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
145
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
49
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.2K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
131